NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019.


Journal

Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515

Informations de publication

Date de publication:
02 2020
Historique:
entrez: 6 2 2020
pubmed: 6 2 2020
medline: 9 2 2021
Statut: ppublish

Résumé

The NCCN Guidelines for Uveal Melanoma include recommendations for staging, treatment, and follow-up of patients diagnosed with uveal melanoma of the choroid or ciliary body. In addition, because distinguishing between uveal melanoma and benign uveal nevi is in some cases difficult, these guidelines also contain recommendations for workup of patients with suspicious pigmented uveal lesions, to clarify the tests needed to distinguish between those who should have further workup and treatment for uveal melanoma versus those with uncertain diagnosis and low risk who should to be followed and later reevaluated. These NCCN Guidelines Insights describe recommendations for treatment of newly diagnosed nonmetastatic uveal melanoma in patients who have already undergone a complete workup.

Identifiants

pubmed: 32023525
doi: 10.6004/jnccn.2020.0007
pii: jnccnGLINS1802
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

120-131

Auteurs

P Kumar Rao (PK)

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

Christopher Barker (C)

Memorial Sloan Kettering Cancer Center.

Daniel G Coit (DG)

Memorial Sloan Kettering Cancer Center.

Richard W Joseph (RW)

Mayo Clinic Cancer Center.

Miguel Materin (M)

Duke Cancer Institute.

Ramesh Rengan (R)

Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.

Jeffrey Sosman (J)

Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

John A Thompson (JA)

Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.

Mark R Albertini (MR)

University of Wisconsin Carbone Cancer Center.

Genevieve Boland (G)

Massachusetts General Hospital Cancer Center.

William E Carson Iii (WE)

The Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute.

Carlo Contreras (C)

O'Neal Comprehensive Cancer Center at UAB.

Gregory A Daniels (GA)

UC San Diego Moores Cancer Center.

Dominick DiMaio (D)

Fred & Pamela Buffett Cancer Center.

Alison Durham (A)

University of Michigan Rogel Cancer Center.

Ryan C Fields (RC)

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

Martin D Fleming (MD)

The University of Tennessee Health Science Center.

Anjela Galan (A)

Yale Cancer Center/Smilow Cancer Hospital.

Brian Gastman (B)

Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Kenneth Grossman (K)

Huntsman Cancer Institute at the University of Utah.

Valerie Guild (V)

AIM at Melanoma.

Douglas Johnson (D)

Vanderbilt-Ingram Cancer Center.

Giorgos Karakousis (G)

Abramson Cancer Center at the University of Pennsylvania.
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Kim Margolin (K)

City of Hope National Medical Center.

Sameer Nath (S)

University of Colorado Cancer Center.

Anthony J Olszanski (AJ)

Fox Chase Cancer Center.

Patrick A Ott (PA)

Dana-Farber/Brigham and Women's Cancer Center.

Merrick I Ross (MI)

The University of Texas MD Anderson Cancer Center.

April K Salama (AK)

Duke Cancer Institute.

Joseph Skitzki (J)

Roswell Park Comprehensive Cancer Institute.

Susan M Swetter (SM)

Stanford Cancer Institute.

Evan Wuthrick (E)

Moffitt Cancer Center; and.

Nicole R McMillian (NR)

National Comprehensive Cancer Network.

Anita Engh (A)

National Comprehensive Cancer Network.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH